Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 2, 2009, Pages 129-132

  Ozgoli, Giti ^a   Goli, Marjan ^b   Moattar, Fariborz ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GINGER EXTRACT; IBUPROFEN; MEFENAMIC ACID; UNCLASSIFIED DRUG; ZINTOMA;

ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG EFFECT; DYSMENORRHEA; FEMALE; GINGER; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; PAIN ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; POWDER; PRIORITY JOURNAL; RHIZOME; SCORING SYSTEM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOUBLE-BLIND METHOD; DYSMENORRHEA; FEMALE; GINGER; HUMANS; IBUPROFEN; MEFENAMIC ACID; PATIENT SATISFACTION; PHYTOTHERAPY; PLANT PREPARATIONS; RHIZOME; YOUNG ADULT;

EID: 60749106134     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0311     Document Type: Article

References (30)

1. Rapkin AJ, Howe CN. Pelvic Pain and Dysmenorrhea, 14th ed. In: Berek JS, ed. Philadelphia: Lippincott Williams & Wilkins, 2007:506-541.
2. Coco AS. Primary dysmenorrhea. Am Fam Physician 1999;60:489-496.
3. Speroff L, Fritz MA. Clinical Gynecologic Endocrinology and Infertility, 7th ed. Philadelphia: Lippincott Williams & Wilkins, 2005:540-541.
4. Dawood MY. Primary dysmenorrhea: Advances in pathogenesis and management. Obstet Gynecol 2006;108:428-441.
5. Burke A, Smyth EM, FitzGerald GA. Analgesic-Antipyretic and Antiinflammatory Agents; Pharmacotherapy of Gout. In: Brunton L, Lazo J, Parker K, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed. New York: McGraw-Hill Professional, 2006:671-716.
6. Proctor ML, Murphy PA. Herbal and dietary therapies for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2001;(3):CD002124.
7. Proctor ML, Murphy PA, Pattison HM, et al. Behavioural interventions for primary and secondary dysmenorrhoea. Cochrane Database Syst Rev 2007 Jul 18;(3):CD002248.
8. Taylor D, Miaskowski C, Kohn J. A randomized clinical trial of the effectiveness of an acupressure device (Relief Brief) for managing symptoms of dysmenorrhea. J Altern Complement Med 2002;8:357-370.
9. Han SH, Hur MH, Buckle J, et al. Effect of aromatherapy on symptoms of dysmenorrhea in college students: A randomized placebo-controlled clinical trial. J Altern Complement Med 2006;12:535-541.
10. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food Chem Toxicol 2008;46:409-420.
11. Dermarderosian A, Beutler JA. Review of Natural Products. St. Louis: Facts and Comparisons, 2000:243-246.
12. Blumenthal M, Busse WR. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Austin: Lippincott Williams & Wilkins, 1998:136.
13. Kim SO, Kundu JK, Shin YK, et al. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-kappaB in phorbol ester-stimulated mouse skin. Oncogene 2005;24:2558-2567.
14. Mills S, Bone K. Principles and Practice of Phytotherapy: Modern Herbal Medicine. Edinburgh: Churchill Livingstone, 2000:394-400.
15. Ibn-Sina HA. The Canon of Medicine. Farsi translation by Sharafkandi, 5th ed. Tehran: Soroosh, 1991:134.
16. Namavar JB, Tartifizadeh A, Khabnadideh S. Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea. Int J Gynaecol Obstet 2003;80:153-157.
17. French L. Dysmenorrhea. Am Fam Physician 2005;71:285-291.
18. Khorshidi N, Ostad SN, Mosaddegh M, Soodi M. Clinical effects of fennel essential oil on primary dysmenorrhea. Iran J Pharmaceut Res 2003;2:89-93.
19. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum 2001;44:2531-2538.
20. Kim JK, Kim Y, Na KM, et al. [6]-Gingerol prevents UVB-induced ROS production and COX-2 expression in vitro and in vivo. Free Radic Res 2007;41:603-614.
21. Lantz RC, Chen GJ, Sarihan M, et al. The effect of extracts from ginger rhizome on inflammatory mediator production. Phytomedicine 2007;14:123-128.
22. Grzanna R, Lindmark L, Frondoza CG. Ginger - An herbal medicinal product with broad anti-inflammatory actions. J Med Food 2005;8:125-132.
23. Levine ME, Gillis MG, Koch SY, et al. Protein and ginger for the treatment of chemotherapy-induced delayed nausea. J Altern Complement Med 2008;14:545-551.
24. Boone SA, Shields KM. Treating pregnancy-related nausea and vomiting with ginger. Ann Pharmacother 2005;39:1710-1713.
25. Chaiyakunapruk N, Kitikannakorn N, Nathisuwan S, et al. The efficacy of ginger for the prevention of postoperative nausea and vomiting: a meta-analysis. Am J Obstet Gynecol 2006;194:95-99.
26. Desai HG, Kalro RH, Choksi AP. Effect of ginger and garlic on DNA content of gastric aspirate. Indian J Med Res 1990;92:139-141.
27. Futrell JM, Rietschel RL. Spice allergy evaluated by results of patch tests. Cutis 1993;52:288-290.
28. Ginger. Online document at: www.vitamins-supplements. org/herbal-supplements/ginger.php Accessed December 11, 2008.
29. Abebe W. Herbal medication: Potential for adverse interactions with analgesic drugs. J Clin Pharm Ther 2002;27:391-401.
30. Zick SM, Blumea A, Normolle D, Ruffin M. Challenges in herbal research: A randomized clinical trial to assess blinding with ginger. Complement Ther Med 2005;13:101-106.